C4U
Funding Series
Series C
Funding Amount
1,500,000
[data from INITIAL 2024 Dec]
Healthcare/Medtech

About

C4U is a biotech spinout originating from The University of Osaka that aims to develop new gene therapy methods a​nd apply them to a wide range of industries using CRISPR-Cas3.

Milestone

Using the genome editing technology CRISPR-Cas3, C4U develops industrial applications to combat diseases that currently have no effective treatments.
Visit Site
We're Here to Help
Have questions? Not sure where to start? Send us an email and let’s chat!
Email Us
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.